Information Library
Results for: Cardiovascular - Enrollment & retention
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Constant Vigilance
Case Study — March 16, 2011
Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met. -
Pioneering Strategy
Case Study — May 13, 2010
Find out how a pharmaceutical company used the clinical trial educator strategy to accelerate enrollment in a multi-country cardiovascular clinical trial. -
Regulatory Landscapes for Future Antidiabetic Drug Development
Hear from the Experts — May 12, 2010
In the March 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the EMA Guidance on diabetes drugs and cardiovascular risk. -
NHS Motivating Patients
Case Study — May 7, 2010
In 2008, the NHS announced plans to offer free health checks for heart disease, stroke, diabetes and kidney disease. Learn why Quintiles was the right ally for the NHS to successfully launch this cardio risk assessment program. -
Data-Driven Patient Recruitment
White Paper — March 23, 2010
Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials. -
Trumping Expectations
Case Study — March 1, 2010
Quintiles sails past recruitment hurdles with tailored approaches that build momentum -
Sub-Saharan Africa Phase II/III Fact Sheet
Brochure — July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. -
QUINTILES ANNOUNCES NEW GHANA OFFICE
Press Release — June 16, 2009 - To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles announced the opening of a new office in Accra, Ghana.
-
Cardiovascular Expertise Results in Faster Enrollment Speed
Case Study — March 27, 2009
Mega-trials require mega-expertise, especially when the global study is for an innovative cardiovascular drug to treat patients with acute coronary syndrome who have also undergone coronary artery bypass surgery.
Page 1 of 1 (9 results)